{
    "nct_id": "NCT04298242",
    "official_title": "A Phase I Study of Magnetic Resonance Guided High Intensity Focused Ultrasound for Treatment of Advanced Pancreatic Adenocarcinoma",
    "inclusion_criteria": "* Men and women ≥ 18 years of age\n* Patients willing to sign a written informed consent document\n* Patients with unresectable, locally advanced or metastatic pancreatic adenocarcinoma\n* Patients with upper abdominal pain rating at least 4 out of 10 in severity on BPI\n* Tumor must be visualized on CT or MRI, obtained within 30 days of enrollment\n* Tumor must be accessible to the ExAblate MRgFUS device\n* Life expectancy ≥ 3 months, as determined by oncologist and documented in chart\n* ECOG performance status of 0, 1, or 2\n* INR < 1.6, platelet count > 50,000 microL\n* Serum urate, calcium, potassium, phosphate, creatinine < 1.5x upper limit of normal\n* Patients can receive general anesthesia, as determined by anesthesiologist\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Previous pancreatic surgery\n* Patients with contraindication for MR imaging such as implanted metallic devices that are not MRI-safe, size limitations, claustrophobia, etc.\n* Patients with known intolerance or allergy to MR contrast agent (gadolinium chelates) including advanced kidney disease (GFR <30 mL/min/1.73 m2) or on dialysis\n* Pregnant and nursing patients will be excluded from the study because of a contraindication to administering MRI contrast agents to these patients\n* Patients unable to receive general anesthesia\n* Target is:\n\n  1. NOT visible by non-contrast MRI, OR\n  2. NOT accessible to ExAblate device\n* Individuals who are not able or willing to tolerate the required prolonged stationary position during treatment (can be up to 6 hrs of total table time)\n* Patients with acute medical condition (e.g. pneumonia, sepsis) that is expected to hinder them from completing this study\n* Patients with unstable cardiac status including:\n\n  1. Unstable angina pectoris on medication\n  2. Patients with documented myocardial infarction within six months of protocol entry\n  3. Congestive heart failure requiring medication (other than diuretic)\n  4. Patients on anti-arrhythmic drugs\n  5. Patients with severe hypertension (diastolic BP > 100 on medication)\n  6. Patients with severe hematologic, neurologic, or other uncontrolled disease (e.g. platelets < 50,000/microL, INR > 1.5)\n* Patients who are taking anti-thrombotic medication\n* Severe cerebrovascular disease (multiple CVAs or CVA within 6 months)",
    "miscellaneous_criteria": ""
}